Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 1/2017

01-03-2017 | Original Research

Long-Term Outcomes and Prognostic Factors in Periampullary Carcinoma

Authors: Bhanu Jayanand Sunil, Ramakrishnan A Seshadri, S. Gouthaman, Rama Ranganathan

Published in: Journal of Gastrointestinal Cancer | Issue 1/2017

Login to get access

Abstract

Purpose

The aim of the study was to analyze the long-term survival and the various prognostic factors that influence overall survival in patients undergoing pancreaticoduodenectomy (PD) with non-pancreatic periampullary carcinomas.

Methods

A retrospective analysis of consecutive patients diagnosed with non-pancreatic periampullary carcinomas who underwent PD at a tertiary cancer center was performed. Univariate analysis of various prognostic factors influencing the disease-free survival (DFS) was performed using log-rank test. Factors identified to be significant in univariate analysis were included in the multivariate analysis, which was performed using the Cox proportional hazard model. The survival estimates were calculated by life-table method. Statistical significance was considered when p value was <0.05. The SPSS v16.0.1 software was used for statistical analysis.

Results

Between 1995 and 2010, 78 patients underwent PD with or without (Whipple’s operation) pylorus preservation for non-pancreatic periampullary adenocarcinomas. Of these, eight patients received adjuvant chemotherapy. The most common subsite was ampulla (60 patients), followed by the second part duodenum (11 patients), and distal common bile duct (7 patients). The median duration of follow-up of all patients in this study was 50 months. The recurrence rate was 39.7 %. The 5-year disease-free survival and overall survival was 57 %. Patients without nodal metastasis had a non-significant trend towards better 5-year disease-free survival when compared to those with nodal metastasis (64 vs 45 %, p = 0.11). On multivariate analysis, it was found that male gender (p = 0.05) and presence of lymphovascular invasion (p = 0.04) predicted a significantly poor 5-year disease-free survival.

Conclusion

Periampullary carcinomas have a favorable prognosis after surgery. Male gender and presence of lymphovascular invasion are independent prognostic factors in patients diagnosed with non-pancreatic periampullary carcinomas who underwent PD in this study.
Literature
1.
go back to reference Samiento JM, Nagomey DM, Sarr MG, Farnell MB. Periampullary cancers: are there differences? Surg Clin North Am. 2001;81:543–55.CrossRef Samiento JM, Nagomey DM, Sarr MG, Farnell MB. Periampullary cancers: are there differences? Surg Clin North Am. 2001;81:543–55.CrossRef
2.
4.
go back to reference Chan C, Herrera MF, de la Garza L, Quintanilla-Martinez L, Vargas-Vorackova F, Richaud-Patín Y, et al. Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg. 1995;222(5):632–7.CrossRefPubMedPubMedCentral Chan C, Herrera MF, de la Garza L, Quintanilla-Martinez L, Vargas-Vorackova F, Richaud-Patín Y, et al. Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg. 1995;222(5):632–7.CrossRefPubMedPubMedCentral
6.
go back to reference Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours, 7th edition. 2010. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours, 7th edition. 2010.
7.
go back to reference Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8–13.CrossRefPubMed Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8–13.CrossRefPubMed
8.
go back to reference Kim RD, Kundhal PS, McGilvray ID, Cattral MS, Taylor B, Langer B, Grant DR, Zogopoulos G, Shah SA, Greig PD, Gallinger S. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg. 2006;202(1):112–9.CrossRefPubMed Kim RD, Kundhal PS, McGilvray ID, Cattral MS, Taylor B, Langer B, Grant DR, Zogopoulos G, Shah SA, Greig PD, Gallinger S. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg. 2006;202(1):112–9.CrossRefPubMed
9.
go back to reference Jean HK, Jeekel J, Sahmoud T, Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cooperative group. Ann Surg. 1999;230(6):776–84.CrossRef Jean HK, Jeekel J, Sahmoud T, Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cooperative group. Ann Surg. 1999;230(6):776–84.CrossRef
10.
go back to reference Qiao QL, Zhao YG, Ye ML, Yang YM, Zhao JX, Huang YT, Wan YL. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg. 2007;31(1):137–43 .discussion 144-6CrossRefPubMed Qiao QL, Zhao YG, Ye ML, Yang YM, Zhao JX, Huang YT, Wan YL. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg. 2007;31(1):137–43 .discussion 144-6CrossRefPubMed
11.
go back to reference Ioannis H, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol. 2010;17(4):991–7. doi:10.1245/s10434-009-0883-9.CrossRef Ioannis H, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol. 2010;17(4):991–7. doi:10.​1245/​s10434-009-0883-9.CrossRef
12.
go back to reference Charles JY, Sohn TA, Cameron JL, Hruban RH, Uiemoe KD, Pitt HA. Periampullary adenocarcinoma analysis of 5-year survivors. Ann Surg. 1998;227(6):821–31.CrossRef Charles JY, Sohn TA, Cameron JL, Hruban RH, Uiemoe KD, Pitt HA. Periampullary adenocarcinoma analysis of 5-year survivors. Ann Surg. 1998;227(6):821–31.CrossRef
13.
go back to reference Di Giorgio A, Alfieri S, Rotondi F, Prete F, Di Miceli D, Ridolfini MP, Rosa F, Covino M, Doglietto GB. Pancreatoduodenectomy for tumors of Vater’s ampulla: report on 94 consecutive patients. World J Surg. 2005;29(4):513–8.CrossRefPubMed Di Giorgio A, Alfieri S, Rotondi F, Prete F, Di Miceli D, Ridolfini MP, Rosa F, Covino M, Doglietto GB. Pancreatoduodenectomy for tumors of Vater’s ampulla: report on 94 consecutive patients. World J Surg. 2005;29(4):513–8.CrossRefPubMed
14.
go back to reference Bucher P, Chassot G, Durmishi Y, Ris F, Morel P. Long-term results of surgical treatment of Vater’s ampulla neoplasms. Hepato-Gastroenterology. 2007;54(76):1239–42.PubMed Bucher P, Chassot G, Durmishi Y, Ris F, Morel P. Long-term results of surgical treatment of Vater’s ampulla neoplasms. Hepato-Gastroenterology. 2007;54(76):1239–42.PubMed
15.
go back to reference George AP, Huang LC, Cameron JL, Tuli R, Lan L, Hruban RH, Pawlik TM, Herman JM, Edil BH, Ahuja N, Choti MA, Wolfgang CL, Schulick RD. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol. 2012;19(6):1928–35. doi:10.1245/s10434-011-2168-3.CrossRef George AP, Huang LC, Cameron JL, Tuli R, Lan L, Hruban RH, Pawlik TM, Herman JM, Edil BH, Ahuja N, Choti MA, Wolfgang CL, Schulick RD. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol. 2012;19(6):1928–35. doi:10.​1245/​s10434-011-2168-3.CrossRef
16.
go back to reference Feng JF, Zhou XM, Mao WM. Prognostic analysis of carcinoma of the ampulla of Vater: pancreaticoduodenectomy versus local resection. Hippkratia. 2012;16(1):23–8. Feng JF, Zhou XM, Mao WM. Prognostic analysis of carcinoma of the ampulla of Vater: pancreaticoduodenectomy versus local resection. Hippkratia. 2012;16(1):23–8.
17.
go back to reference Wang CH, Mo LR, Lin RC, Kuo JJ, Chang KK, Lin YW, Yang DM, Yau MP, Cho CY. A survival predictive model in patients undergoing radical resection of ampullary adenocarcinoma. Hepato-Gastroenterology. 2004;51(59):1495–9.PubMed Wang CH, Mo LR, Lin RC, Kuo JJ, Chang KK, Lin YW, Yang DM, Yau MP, Cho CY. A survival predictive model in patients undergoing radical resection of ampullary adenocarcinoma. Hepato-Gastroenterology. 2004;51(59):1495–9.PubMed
18.
go back to reference Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Furuse J, Saito H, Tsuyuguchi T, Yamamoto M, Kayahara M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Hirano S, Amano H, Miura F. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepato-Biliary-Pancreat Surg. 2008;15:41–54. doi:10.1007/s00534-007-1279-5.CrossRef Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Furuse J, Saito H, Tsuyuguchi T, Yamamoto M, Kayahara M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Hirano S, Amano H, Miura F. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepato-Biliary-Pancreat Surg. 2008;15:41–54. doi:10.​1007/​s00534-007-1279-5.CrossRef
19.
go back to reference Bettschart V, Rahman MQ, Engelken FJ, Madhavan KK, Parks RW, Garden OJ. Presentation, treatment and outcome in patients with ampullary tumours. Br J Surg. 2004;91(12):1600–7.CrossRefPubMed Bettschart V, Rahman MQ, Engelken FJ, Madhavan KK, Parks RW, Garden OJ. Presentation, treatment and outcome in patients with ampullary tumours. Br J Surg. 2004;91(12):1600–7.CrossRefPubMed
20.
go back to reference Sakata J, Shirai Y, Wakai T, Yokoyama N, Sakata E, Akazawa K, Hatakeyama K. Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma. Eur J Surg Oncol. 2007;33(3):346–51.CrossRefPubMed Sakata J, Shirai Y, Wakai T, Yokoyama N, Sakata E, Akazawa K, Hatakeyama K. Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma. Eur J Surg Oncol. 2007;33(3):346–51.CrossRefPubMed
21.
go back to reference Fritz K, Jacob D, Bahra M, Pelzer U, Puhl G, Krannich A, Andreou A, Gül S, Guckelberger O. Prognostic factors for long-term survival in patients with ampullary carcinoma: the results of a 15-year observation period after pancreaticoduodenectomy. HPB Surg. 2014;2014(2014):Article ID 970234. doi:10.1155/2014/970234.8 pages Fritz K, Jacob D, Bahra M, Pelzer U, Puhl G, Krannich A, Andreou A, Gül S, Guckelberger O. Prognostic factors for long-term survival in patients with ampullary carcinoma: the results of a 15-year observation period after pancreaticoduodenectomy. HPB Surg. 2014;2014(2014):Article ID 970234. doi:10.​1155/​2014/​970234.8 pages
22.
go back to reference Lindell G, Borch K, Tingstedt B, Enell EL, Ihse I. Management of cancer of the ampulla of Vater: does local resection play a role? Dig Surg. 2003;20:511–5.CrossRefPubMed Lindell G, Borch K, Tingstedt B, Enell EL, Ihse I. Management of cancer of the ampulla of Vater: does local resection play a role? Dig Surg. 2003;20:511–5.CrossRefPubMed
23.
go back to reference Joon SP, Yoon DS, Kim KS, Choi JS, Lee WJ, Chi HS, Kim BR. Factors influencing recurrence after curative resection for ampulla of vater carcinoma. J Surg Oncol. 2007;95:286–90.CrossRef Joon SP, Yoon DS, Kim KS, Choi JS, Lee WJ, Chi HS, Kim BR. Factors influencing recurrence after curative resection for ampulla of vater carcinoma. J Surg Oncol. 2007;95:286–90.CrossRef
24.
go back to reference Yeo CJ, Cameron JL, Lillemoe KD et al. (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma—part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236(3):355–68. Yeo CJ, Cameron JL, Lillemoe KD et al. (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma—part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236(3):355–68.
25.
go back to reference Branum GD, Pappas TN, Meyers WC. (1996) The management of tumors of the ampulla of Vater by local resection. Ann Surg. 1996;224:621–7. Branum GD, Pappas TN, Meyers WC. (1996) The management of tumors of the ampulla of Vater by local resection. Ann Surg. 1996;224:621–7.
26.
go back to reference Lee JH, Whittington R, Williams NN, Berry MF, Vaughn DJ, Haller DG, Rosato EF. (2000) Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys. 2000;47(4):945–53. Lee JH, Whittington R, Williams NN, Berry MF, Vaughn DJ, Haller DG, Rosato EF. (2000) Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys. 2000;47(4):945–53.
27.
go back to reference Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T. (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95(8):1685–95. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T. (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95(8):1685–95.
28.
go back to reference Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Oláh A, Rawcliffe CL, Verbeke CS, Campbell F, Büchler MW. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012;308(2):147–56. doi:10.1001/jama.2012.7352. Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Ghaneh P, Halloran CM, Lerch MM, Oláh A, Rawcliffe CL, Verbeke CS, Campbell F, Büchler MW. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012;308(2):147–56. doi:10.​1001/​jama.​2012.​7352.
29.
go back to reference Narang AK, Miller RC, Hsu CC, Bhatia S, Pawlik TM, Laheru D, Hruban RH, Zhou J, Winter JM, Haddock MG, Donohue JH, Schulick RD, Wolfgang CL, Cameron JL, Herman JM. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Radiat Oncol. 2011;6:126. doi:10.1186/1748-717X-6-126. Narang AK, Miller RC, Hsu CC, Bhatia S, Pawlik TM, Laheru D, Hruban RH, Zhou J, Winter JM, Haddock MG, Donohue JH, Schulick RD, Wolfgang CL, Cameron JL, Herman JM. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Radiat Oncol. 2011;6:126. doi:10.​1186/​1748-717X-6-126.
Metadata
Title
Long-Term Outcomes and Prognostic Factors in Periampullary Carcinoma
Authors
Bhanu Jayanand Sunil
Ramakrishnan A Seshadri
S. Gouthaman
Rama Ranganathan
Publication date
01-03-2017
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2017
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-016-9863-z

Other articles of this Issue 1/2017

Journal of Gastrointestinal Cancer 1/2017 Go to the issue